Receive regular headline summaries whenever high-quality news is generated for Clinical AI Platform. We'll never share your email address with others.
|Shares Healthcare News With (link):|
|Other Healthcare Entities||We are still establishing shared news links for this healthcare topic.|
|Date||Headline (link)||Source||Relevant Snippet|
|10/10/2019||Bayer, Sensyne spin AI collaboration into global LifeHub imaging project||FierceBiotech||... on its own area of expertise. The AI-powered imaging solutions the latest program hopes to develop will focus on both disease detection and drug discovery. Its first project includes the development of a clinical AI platform for automated image evaluation and computer-aided diagnosis. RELATED: Bayer teams up with AI firm Sensyne Health to mine NHS data for its heart disease pipeline “Initiatives like this are essential to quickly ...|
|6/25/2019||EY, Sensyne Health and Guardtime to use AI and blockchain to link health care reimbursement and actual patient outcomes||PR Newswire||... automated business process experience to allow pharmaceutical companies and health care providers to share data and help manage real-world outcomes-based contracts at scale with transparency and trust. Sensyne Health will use its clinical AI platform to evaluate patient health impact. Guardtime will run its HSX bridge software, built on the KSI blockchain. Through this technology, health care data will be transported securely with a transparent audit trail allowing ...|
|5/6/2019||SIME Completes Study Validating Clinical AI Platform in Neonatal Respiratory Care||PR Newswire||LONDON , May 6, 2019 /PRNewswire/ -- SIME, a Clinical AI company generating unique biological data to deliver life-saving solutions, today announced the publication of its pivotal ' Fast Assessment of Lung Maturity at Birth ' study. The study validates the first application on the company's patented AI Platform: a rapid point-of-care neonatal Lung Maturity Test (LMT) [ doi.org/10.1111/apa.14831 ] Building on previous clinical data published in 2016 , the ' Fast ...|
|5/6/2019||SIME Completes Study Validating Clinical AI Platform in Neonatal Respiratory Care||BioSpace||SIME Completes Study Validating Clinical AI Platform in Neonatal Respiratory Care Published: May 06, 2019 Data demonstrating that AI accurately predicts Respiratory Distress Syndrome (RDS) in premature babies, enables company to accelerate product development and begin next phase clinical studies in Europe, the US and China LONDON , May 6, 2019 /PRNewswire/ -- SIME , a Clinical AI company generating unique biological data to deliver life-saving solutions, today announced the publication of ...|